187 related articles for article (PubMed ID: 18790783)
1. Novel opportunities for thymidylate metabolism as a therapeutic target.
Wilson PM; Fazzone W; LaBonte MJ; Deng J; Neamati N; Ladner RD
Mol Cancer Ther; 2008 Sep; 7(9):3029-37. PubMed ID: 18790783
[TBL] [Abstract][Full Text] [Related]
2. The role of dUTPase and uracil-DNA repair in cancer chemotherapy.
Ladner RD
Curr Protein Pept Sci; 2001 Dec; 2(4):361-70. PubMed ID: 12374095
[TBL] [Abstract][Full Text] [Related]
3. Regulation of human dUTPase gene expression and p53-mediated transcriptional repression in response to oxaliplatin-induced DNA damage.
Wilson PM; Fazzone W; LaBonte MJ; Lenz HJ; Ladner RD
Nucleic Acids Res; 2009 Jan; 37(1):78-95. PubMed ID: 19015155
[TBL] [Abstract][Full Text] [Related]
4. dUTPase inhibition confers susceptibility to a thymidylate synthase inhibitor in DNA-repair-defective human cancer cells.
Yokogawa T; Yano W; Tsukioka S; Osada A; Wakasa T; Ueno H; Hoshino T; Yamamura K; Fujioka A; Fukuoka M; Ohkubo S; Matsuo K
Cancer Sci; 2021 Jan; 112(1):422-432. PubMed ID: 33140501
[TBL] [Abstract][Full Text] [Related]
5. Small interfering RNA-mediated suppression of dUTPase sensitizes cancer cell lines to thymidylate synthase inhibition.
Koehler SE; Ladner RD
Mol Pharmacol; 2004 Sep; 66(3):620-6. PubMed ID: 15322254
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of dUTPase induces synthetic lethality with thymidylate synthase-targeted therapies in non-small cell lung cancer.
Wilson PM; LaBonte MJ; Lenz HJ; Mack PC; Ladner RD
Mol Cancer Ther; 2012 Mar; 11(3):616-28. PubMed ID: 22172489
[TBL] [Abstract][Full Text] [Related]
7. dUTP nucleotidohydrolase isoform expression in normal and neoplastic tissues: association with survival and response to 5-fluorouracil in colorectal cancer.
Ladner RD; Lynch FJ; Groshen S; Xiong YP; Sherrod A; Caradonna SJ; Stoehlmacher J; Lenz HJ
Cancer Res; 2000 Jul; 60(13):3493-503. PubMed ID: 10910061
[TBL] [Abstract][Full Text] [Related]
8. Deoxyuridine triphosphatase (dUTPase) expression and sensitivity to the thymidylate synthase (TS) inhibitor ZD9331.
Webley SD; Hardcastle A; Ladner RD; Jackman AL; Aherne GW
Br J Cancer; 2000 Sep; 83(6):792-9. PubMed ID: 10952785
[TBL] [Abstract][Full Text] [Related]
9. dUTPase inhibition augments replication defects of 5-Fluorouracil.
Hagenkort A; Paulin CBJ; Desroses M; Sarno A; Wiita E; Mortusewicz O; Koolmeister T; Loseva O; Jemth AS; Almlöf I; Homan E; Lundbäck T; Gustavsson AL; Scobie M; Helleday T
Oncotarget; 2017 Apr; 8(14):23713-23726. PubMed ID: 28423595
[TBL] [Abstract][Full Text] [Related]
10. TAS-114, a First-in-Class Dual dUTPase/DPD Inhibitor, Demonstrates Potential to Improve Therapeutic Efficacy of Fluoropyrimidine-Based Chemotherapy.
Yano W; Yokogawa T; Wakasa T; Yamamura K; Fujioka A; Yoshisue K; Matsushima E; Miyahara S; Miyakoshi H; Taguchi J; Chong KT; Takao Y; Fukuoka M; Matsuo K
Mol Cancer Ther; 2018 Aug; 17(8):1683-1693. PubMed ID: 29748212
[TBL] [Abstract][Full Text] [Related]
11. The ability to accumulate deoxyuridine triphosphate and cellular response to thymidylate synthase (TS) inhibition.
Webley SD; Welsh SJ; Jackman AL; Aherne GW
Br J Cancer; 2001 Aug; 85(3):446-52. PubMed ID: 11487279
[TBL] [Abstract][Full Text] [Related]
12. Structure/function analysis of a dUTPase: catalytic mechanism of a potential chemotherapeutic target.
Harris JM; McIntosh EM; Muscat GE
J Mol Biol; 1999 Apr; 288(2):275-87. PubMed ID: 10329142
[TBL] [Abstract][Full Text] [Related]
13. dUTPase and uracil-DNA glycosylase are central modulators of antifolate toxicity in Saccharomyces cerevisiae.
Tinkelenberg BA; Hansbury MJ; Ladner RD
Cancer Res; 2002 Sep; 62(17):4909-15. PubMed ID: 12208740
[TBL] [Abstract][Full Text] [Related]
14. Targeting nucleotide metabolism enhances the efficacy of anthracyclines and anti-metabolites in triple-negative breast cancer.
Davison C; Morelli R; Knowlson C; McKechnie M; Carson R; Stachtea X; McLaughlin KA; Prise VE; Savage K; Wilson RH; Mulligan KA; Wilson PM; Ladner RD; LaBonte MJ
NPJ Breast Cancer; 2021 Apr; 7(1):38. PubMed ID: 33824328
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of thymidylate synthase expression and its steady-state mRNA by oxaliplatin in colon cancer cells.
Yeh KH; Cheng AL; Wan JP; Lin CS; Liu CC
Anticancer Drugs; 2004 Apr; 15(4):371-6. PubMed ID: 15057142
[TBL] [Abstract][Full Text] [Related]
16. Expression of uracil DNA glycosylase (UDG) does not affect cellular sensitivity to thymidylate synthase (TS) inhibition.
Welsh SJ; Hobbs S; Aherne GW
Eur J Cancer; 2003 Feb; 39(3):378-87. PubMed ID: 12565992
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of Human Uracil DNA Glycosylase Sensitizes a Large Fraction of Colorectal Cancer Cells to 5-Fluorodeoxyuridine and Raltitrexed but Not Fluorouracil.
Christenson ES; Gizzi A; Cui J; Egleston M; Seamon KJ; DePasquale M; Orris B; Park BH; Stivers JT
Mol Pharmacol; 2021 Jun; 99(6):412-425. PubMed ID: 33795350
[TBL] [Abstract][Full Text] [Related]
18. The novel anti-cancer fluoropyrimidine NUC-3373 is a potent inhibitor of thymidylate synthase and an effective DNA-damaging agent.
Bré J; Dickson AL; Read OJ; Zhang Y; McKissock FG; Mullen P; Tang P; Zickuhr GM; Czekster CM; Harrison DJ
Cancer Chemother Pharmacol; 2023 May; 91(5):401-412. PubMed ID: 37000221
[TBL] [Abstract][Full Text] [Related]
19. The 1,2-Diaminocyclohexane Carrier Ligand in Oxaliplatin Induces p53-Dependent Transcriptional Repression of Factors Involved in Thymidylate Biosynthesis.
Kiyonari S; Iimori M; Matsuoka K; Watanabe S; Morikawa-Ichinose T; Miura D; Niimi S; Saeki H; Tokunaga E; Oki E; Morita M; Kadomatsu K; Maehara Y; Kitao H
Mol Cancer Ther; 2015 Oct; 14(10):2332-42. PubMed ID: 26208523
[TBL] [Abstract][Full Text] [Related]
20. Thymidylate synthase: a critical target in cancer therapy?
Rustum YM
Front Biosci; 2004 Sep; 9():2467-73. PubMed ID: 15353299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
